Dhanya Sooraj

ORCID: 0000-0002-3176-3305
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Histone Deacetylase Inhibitors Research
  • Protein Degradation and Inhibitors
  • Epigenetics and DNA Methylation
  • Chromatin Remodeling and Cancer
  • Glioma Diagnosis and Treatment
  • RNA modifications and cancer
  • Cancer-related gene regulation
  • Molecular Biology Techniques and Applications
  • RNA and protein synthesis mechanisms
  • Angiogenesis and VEGF in Cancer
  • Neuroblastoma Research and Treatments
  • Marine Sponges and Natural Products
  • ATP Synthase and ATPases Research
  • Phagocytosis and Immune Regulation
  • Adenosine and Purinergic Signaling
  • CRISPR and Genetic Engineering
  • Inflammasome and immune disorders
  • Genomics and Phylogenetic Studies
  • Genomics and Chromatin Dynamics
  • Sympathectomy and Hyperhidrosis Treatments
  • Vanadium and Halogenation Chemistry
  • Peptidase Inhibition and Analysis
  • Genetics and Neurodevelopmental Disorders
  • Cancer-related Molecular Pathways
  • Lymphatic System and Diseases

Monash University
2011-2023

Hudson Institute of Medical Research
2016-2023

Monash Institute of Medical Research
2011-2014

Data61
2012

The University of Melbourne
2012

Abstract Motivation: Shotgun sequence read data derived from xenograft material contains a mixture of reads arising the host and graft. Classifying to separate two allows for more precise analysis be performed. Results: We present technique, with an associated tool Xenome, which performs fast, accurate specific classification xenograft-derived data. have evaluated it on RNA-Seq human, mouse human-in-mouse datasets. Availability: Xenome is available non-commercial use...

10.1093/bioinformatics/bts236 article EN cc-by-nc Bioinformatics 2012-06-09

Aberrant activation of Wnt/β-catenin pathway is a key driver colorectal cancer (CRC) growth and great therapeutic importance. In this study, we performed comprehensive CRISPR screens to interrogate the regulatory network signaling in CRC cells. We found marked discrepancies between artificial TOP reporter activity β-catenin-mediated endogenous transcription redundant roles T cell factor/lymphoid enhancer factor factors transducing β-catenin signaling. Compiled functional genomic analysis...

10.1126/sciadv.abf2567 article EN cc-by-nc Science Advances 2021-05-19

Initiation and maintenance of transcriptional states are critical for controlling normal tissue homeostasis differentiation. The cyclin dependent kinases CDK8 CDK19 (Mediator kinases) regulatory components Mediator, a highly conserved complex that orchestrates enhancer-mediated output. While Mediator have been implicated in the transcription genes necessary development growth, its function mammals has not well defined. Using genetically defined models pharmacological inhibitors, we showed...

10.1172/jci158593 article EN cc-by Journal of Clinical Investigation 2022-08-25

Improved treatment strategies are required for bladder cancer due to frequent recurrence of low-grade tumors and poor survival rate from high-grade with current therapies. Histone deacetylase inhibitors (HDACi), approved as single agents specific lymphomas, have shown promising preclinical results in solid but could benefit identification biomarkers response. Loss activating transcription factor 3 (ATF3) expression is a feature tumor progression correlates survival. We investigated the...

10.1158/1535-7163.mct-15-0890 article EN Molecular Cancer Therapeutics 2016-04-26

Here we investigate the function of innate immune molecule protein kinase R (PKR) in intestinal inflammation. To model a colitogenic role PKR, determine physiological response to dextran sulfate sodium (DSS) wild-type and two transgenic mice strains mutated express either kinase-dead PKR or ablate expression kinase. These experiments recognize kinase-dependent -independent protection from DSS-induced weight loss inflammation, against increase susceptibility injury. We propose these effects...

10.3389/fimmu.2023.1106737 article EN cc-by Frontiers in Immunology 2023-02-17

Abstract Cell lines represent the most versatile and widely used models of cancer and, as such, are critical for identifying advancing new therapies. Strikingly, there is a significant gap in both number childhood brain cell their characterisation compared to adult counterparts. To address this inequity, we established line atlas (publicly available at vicpcc.org.au/dashboard) encompassing over 180 CNS-derived lines, representing 20 tumour types 11 molecular subtypes. characterized by whole...

10.1093/neuonc/noac079.640 article EN cc-by-nc Neuro-Oncology 2022-06-01

Abstract BACKGROUND: Bladder cancer is the fifth most common affecting Western world. About 90% of bladder superficial and remaining 10% muscle invasive. Surgery followed by platinum based chemotherapy standard treatment for high grade tumors, results in <50% 5 year survival rate following surgery. ATF3 can play a key role as either an oncogenic suppressor or inducer depending on degree malignancy. Decreased expression has been associated with tumor progression reduced [1]....

10.1158/1538-7445.am2014-387 article EN Cancer Research 2014-10-01

<p>Figure S1. Pracinostat reactivates acetylation of non-histone protein tubulin at higher doses. Figure S2. Alteration in malignant behavior cancer cell lines vitro with treatment. S3. ATF3 regulates the transcriptional activation RB1. S4. treatment inhibits vivo tumor growth. S5. production proangiogenic factor VEGF- A vitro. S6. reactivation is crucial determining sensitivity HDACi bladder cancer. S7. The level expression HDAC enzymes may dictate degree different Supplementary...

10.1158/1535-7163.22508952.v1 preprint EN cc-by 2023-04-03

<p>Figure S1. Pracinostat reactivates acetylation of non-histone protein tubulin at higher doses. Figure S2. Alteration in malignant behavior cancer cell lines vitro with treatment. S3. ATF3 regulates the transcriptional activation RB1. S4. treatment inhibits vivo tumor growth. S5. production proangiogenic factor VEGF- A vitro. S6. reactivation is crucial determining sensitivity HDACi bladder cancer. S7. The level expression HDAC enzymes may dictate degree different Supplementary...

10.1158/1535-7163.22508952 preprint EN cc-by 2023-04-03

<div>Abstract<p>Improved treatment strategies are required for bladder cancer due to frequent recurrence of low-grade tumors and poor survival rate from high-grade with current therapies. Histone deacetylase inhibitors (HDACi), approved as single agents specific lymphomas, have shown promising preclinical results in solid but could benefit identification biomarkers response. Loss activating transcription factor 3 (ATF3) expression is a feature tumor progression correlates...

10.1158/1535-7163.c.6539148 preprint EN 2023-04-03

<div>Abstract<p>Improved treatment strategies are required for bladder cancer due to frequent recurrence of low-grade tumors and poor survival rate from high-grade with current therapies. Histone deacetylase inhibitors (HDACi), approved as single agents specific lymphomas, have shown promising preclinical results in solid but could benefit identification biomarkers response. Loss activating transcription factor 3 (ATF3) expression is a feature tumor progression correlates...

10.1158/1535-7163.c.6539148.v1 preprint EN 2023-04-03

Abstract Atypical teratoid rhabdoid tumours (ATRTs) are high-grade malignant paediatric brain with a less than one-year survival rate after diagnosis. Current treatment for ATRT, which includes high-intensive radiotherapy and chemotherapy, results in long-term side effects on ATRT patients. Hence, there is an urgent need to discover targeted therapies that could be used treat patients ATRT. As part of the Hudson Monash Paediatric Precision Medicine Program, we have collected 23 cell lines...

10.1093/neuonc/noaa222.002 article EN cc-by-nc Neuro-Oncology 2020-12-01

Abstract The precise decoding of human genomes facilitated by the advancements in next-generation sequencing has led to a better understanding genetic underpinnings pediatric brain cancers. Indeed, it is now evident that tumours same type harbour distinct driving mutations and molecular aberrations can result different prognosis treatment outcomes. profounder insight into identity, amount types paved way for advent targeted therapies precision medicine. Nevertheless, less than 10% cancer...

10.1093/neuonc/noaa222.594 article EN cc-by-nc Neuro-Oncology 2020-12-01
Coming Soon ...